Graphene oxide (GO) was successfully incorporated into a hybrid lyotropic liquid crystal (LLC) matrix formed by two kinds of surfactants n-dodecyl tetraethylene monoether (C 12 E 4 ) and 1-dodecyl-3-methylimidazolium bromide ionic liquid (C 12 mimBr). By changing the ratios of C 12 E 4 and C 12 mimBr, two types of C 12 E 4 /C 12 mimBr LLC matrixes (lamellar and hexagonal phase) were formed and the effects of the concentration of GO and temperature on the properties of GO/C 12 E 4 /C 12 mimBr LLC composites were systematically investigated by polarized optical microscopy (POM) observations, small-angle X-ray scattering (SAXS) and rheological measurement. Both POM observations and SAXS results indicated that GO can be well-dispersed in the hybrid LLC matrixs at room temperature. Moreover, after the incorporation of GO, the temperature tolerance of
Polymorphism
of cocrystals is a fascinating research topic in the
field of crystal engineering. For the often employed mechanochemical
synthesis approach, the solvent polarity and the stoichiometric ratio
of starting materials were previously confirmed as significant variables
controlling the polymorphic outcomes. In this study, the 1:1 (THP-AH11)
and 1:2 (THP-AH12) theophylline-acesulfame cocrystals were obtained
by using mechanochemical method with different synthesis parameters.
It was found that the solid form of the mechanochemical product can
also be altered by grinding energy and forms of starting materials.
All these effect factors are understandable from the point of view
of energy mechanism, which modified either the energy barrier or the
reaction pathway.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.